Mr Hirsch began working for the company as a consultant in April 2008 and joined the company as a full-time employee in May 2008. Ms Delfino will remain with the company on a consultant basis.
Prior to joining Oni BioPharma, Mr Hirsch operated a boutique legal and consulting practice with a focus on financing and advising emerging technology companies.
Mr Hirsch holds a MSIA (MBA) from the Tepper School of Business at Carnegie Mellon University, a JD from Drake University Law School and a BA in economics from Indiana University.
Stanley Stein, president and CEO of Oni BioPharma, said: “We are certainly excited about having David join us. His breadth of experience in marketing, operations and finance will be very valuable to Oni BioPharma.”